BioStabilization Systems (BoSS)
Health and Human Services, Department of · NATIONAL INSTITUTES OF HEALTH
This notice is not accepting responses (deadline was Mar 25, 2026, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Mar 25, 2026, 8:00 PM EDT
- Posted
- Jan 25, 2026
- Solicitation
- ARPA-H-SOL-26-136
- Set-aside
- None listed
- Place of performance
- Washington, DC, USA
- Contracting office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) · Washington · DC
- Source
- SAM.gov · updated May 14, 2026
Description
Amendment 2: The purpose of this amendment is to amend the BoSS ISO. An updated version of the ISO, with changes in red font, is included as an attachment to this amendment. Changes to the ISO include (but are not limited to): clarification of examples of out-of-scope approaches (Table 1) update to capability requirements (Section 1.3 Program Overview) update to allowable IV&V partner entity types (Section 2) update to reporting requirements (Section 3.4 Programmatic Deliverables) Please carefully review the amended ISO for all changes. ------------------------------------------------------------------------------------------------------------ Amendment 1 corrects a formatting error on references to Table 2. ------------------------------------------------------------------------------------------------------------ Program Description: The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence on ultra-cold conditions (-80 to -196?C) for storage and transport. BoSS will yield a bioprocessing system that enables scalable production of thermally stable cells, paving the way for a new era of efficient and resilient manufacturing and distribution of biologics without any need for cold storage. BoSS-developed technologies will also accelerate many other avenues in biotechnology that directly impact healthcare, including bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, and wound repair, in addition to improving access to a wide range of existing biotherapeutics. Solution Summaries are required: For consideration as a Performer: Solution Summary due date: February 19th, 2026 5:00 PM ET For consideration as an IV&V partner: Solution Summary due date: April 17th, 2026 5:00 PM ET Interested parties are invited to review the attached BoSS Innovative Solutions Opening (ISO) ARPA-H -SOL-26-136. Submissions must be made to: Solution Summary Submission Site: https://solutions.arpa-h.gov/Submit-Solution/ Please ensure to follow this opportunity for any updates. For more information on the BoSS program visit: https://arpa-h.gov/explore-funding/programs/boss. For information on Proposer's Day details and registration information, please see Special Notice ARPA-H-SN-26-137.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$2.05M
Middle of the pack for similar past awards
Most similar awards fall between $599,884 and $3.65M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MAPP BIOPHARMACEUTICAL, INC.1 award$56.70M
- 2THERADEX SYSTEMS, INC.1 award$34.79M
- 3TECHNICAL RESOURCES INTERNATIONAL, INC.2 awards$34.26M
- 4BIOAEGIS THERAPEUTICS INC1 award$20.00M
- 5SYNEDGEN, INC.1 award$18.83M
- 6PARTNER THERAPEUTICS, INC.1 award$12.99M
- 7TRITON SYSTEMS, INC.2 awards$7.59M
- 8OPTOSURGICAL, LLC2 awards$7.00M
Recent examples
A few of the newest similar awards in our index.
- BIOAEGIS THERAPEUTICS INCSep 30, 2025Department of Health and Human Services$20.00MSource
- UNIVERSITY OF ROCHESTERSep 30, 2025Department of Health and Human Services$4.26MSource
- ECS FEDERAL, LLCSep 29, 2025Department of Veterans Affairs$848,402Source
- SYNEDGEN, INC.Sep 26, 2025Department of Health and Human Services$18.83MSource
- GEN1E LIFESCIENCES INC.Sep 19, 2025Department of Health and Human Services$749,000Source
- OCEANIT LABORATORIES INCSep 12, 2025Department of Health and Human Services$597,456Source
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 7b372e473c844a74a0e236e981e972db.